Diagnosis 0 9 0 9 O
of 10 12 10 12 O
primary 13 20 13 20 O
plasma 21 27 21 27 B-cancer
cell 28 32 28 32 I-cancer
leukemia 33 41 33 41 I-cancer

Forced 0 6 42 48 B-clinical_variable
Expiratory 7 17 49 59 I-clinical_variable
Volume 18 24 60 66 I-clinical_variable
1 25 26 67 68 I-clinical_variable
( 27 28 69 70 I-clinical_variable
FEV1 28 32 70 74 I-clinical_variable
) 32 33 74 75 I-clinical_variable
, 33 34 75 76 O
Forced 35 41 77 83 B-clinical_variable
Vital 42 47 84 89 I-clinical_variable
Capacity 48 56 90 98 I-clinical_variable
( 57 58 99 100 I-clinical_variable
FVC 58 61 100 103 I-clinical_variable
) 61 62 103 104 I-clinical_variable
and 63 66 105 108 O
diffusion 67 76 109 118 B-clinical_variable
capacity 77 85 119 127 I-clinical_variable
( 86 87 128 129 I-clinical_variable
DLCO 87 91 129 133 I-clinical_variable
) 91 92 133 134 I-clinical_variable
> 93 94 135 136 O
50 95 97 137 139 B-lower_bound
% 97 98 139 140 I-lower_bound
of 99 101 141 143 O
predicted 102 111 144 153 O

Lactate 0 7 154 161 B-clinical_variable
Dehydrogenase 8 21 162 175 I-clinical_variable
( 22 23 176 177 I-clinical_variable
LDH 23 26 177 180 I-clinical_variable
) 26 27 180 181 I-clinical_variable
≥ 28 29 182 183 O
360 30 33 184 187 B-lower_bound
U 34 35 188 189 I-lower_bound
/ 35 36 189 190 I-lower_bound
L 36 37 190 191 I-lower_bound

Multiple 0 8 192 200 B-clinical_variable
- 8 9 200 201 I-clinical_variable
gated 9 14 201 206 I-clinical_variable
Acquisition 15 26 207 218 I-clinical_variable
Scan 27 31 219 223 I-clinical_variable
( 32 33 224 225 I-clinical_variable
MUGA 33 37 225 229 I-clinical_variable
) 37 38 229 230 I-clinical_variable
scan 39 43 231 235 I-clinical_variable
≥ 44 45 236 237 O
45 46 48 238 240 B-lower_bound
% 48 49 240 241 I-lower_bound

Patients 0 8 242 250 O
must 9 13 251 255 O
be 14 16 256 258 O
at 17 19 259 261 O
least 20 25 262 267 O
18 26 28 268 270 B-lower_bound
years 29 34 271 276 I-lower_bound
of 35 37 277 279 O
age 38 41 280 283 B-age
and 42 45 284 287 O
not 46 49 288 291 O
older 50 55 292 297 O
than 56 60 298 302 O
75 61 63 303 305 B-upper_bound
years 64 69 306 311 I-upper_bound
of 70 72 312 314 O
age 73 76 315 318 O
at 77 79 319 321 O
the 80 83 322 325 O
time 84 88 326 330 O
of 89 91 331 333 O
registration 92 104 334 346 O

Patients 0 8 347 355 O
must 9 13 356 360 O
be 14 16 361 363 O
either 17 23 364 370 O
untreated 24 33 371 380 O
or 34 36 381 383 O
have 37 41 384 388 O
not 42 45 389 392 O
received 46 54 393 401 O
more 55 59 402 406 O
than 60 64 407 411 O
four 65 69 412 416 B-lower_bound
cycles 70 76 417 423 O
of 77 79 424 426 O
systemic 80 88 427 435 B-treatment
MM 89 91 436 438 I-treatment
therapy 92 99 439 446 I-treatment
( 100 101 447 448 O
e.g. 101 105 448 452 O
Revlimid 106 114 453 461 B-treatment
Dexamethasone 115 128 462 475 I-treatment
( 129 130 476 477 I-treatment
RD 130 132 477 479 I-treatment
) 132 133 479 480 I-treatment
, 133 134 480 481 O
Bortezomib 135 145 482 492 B-treatment
Revlimid 146 154 493 501 I-treatment
Dexamethasone 155 168 502 515 I-treatment
( 169 170 516 517 I-treatment
VRD 170 173 517 520 I-treatment
) 173 174 520 521 I-treatment
. 174 175 521 522 O
Prior 176 181 523 528 B-treatment
bisphosphonates 182 197 529 544 I-treatment
and 198 201 545 548 O
localized 202 211 549 558 B-treatment
radiation 212 221 559 568 I-treatment
are 222 225 569 572 O
allowed 226 233 573 580 O

Patients 0 8 581 589 O
must 9 13 590 594 O
have 14 18 595 599 O
a 19 20 600 601 O
platelet 21 29 602 610 B-clinical_variable
count 30 35 611 616 I-clinical_variable
≥ 36 37 617 618 O
50,000 38 44 619 625 B-lower_bound
/ 44 45 625 626 I-lower_bound
μL 45 47 626 628 I-lower_bound

Patients 0 8 629 637 O
must 9 13 638 642 O
have 14 18 643 647 O
adequate 19 27 648 656 O
pulmonary 28 37 657 666 B-clinical_variable
function 38 46 667 675 I-clinical_variable
studies 47 54 676 683 I-clinical_variable
> 55 56 684 685 O
50 57 59 686 688 B-lower_bound
% 59 60 688 689 I-lower_bound
of 61 63 690 692 O
predicted 64 73 693 702 O
on 74 76 703 705 O
mechanical 77 87 706 716 O
aspects 88 95 717 724 O

Patients 0 8 725 733 O
must 9 13 734 738 O
have 14 18 739 743 O
newly 19 24 744 749 O
diagnosed 25 34 750 759 O
active 35 41 760 766 B-cancer
Multiple 42 50 767 775 I-cancer
Myeloma 51 58 776 783 I-cancer
( 59 60 784 785 I-cancer
MM 60 62 785 787 I-cancer
) 62 63 787 788 I-cancer
requiring 64 73 789 798 O
treatment 74 83 799 808 O

Patients 0 8 809 817 O
must 9 13 818 822 O
not 14 17 823 826 O
have 18 22 827 831 O
prior 23 28 832 837 O
malignancy 29 39 838 848 B-cancer
, 39 40 848 849 O
except 41 47 850 856 O
for 48 51 857 860 O
adequately 52 62 861 871 O
treated 63 70 872 879 O
basal 71 76 880 885 B-cancer
cell 77 81 886 890 I-cancer
or 82 84 891 893 O
squamous 85 93 894 902 B-cancer
cell 94 98 903 907 I-cancer
skin 99 103 908 912 I-cancer
cancer 104 110 913 919 I-cancer
, 110 111 919 920 O
in 112 114 921 923 O
situ 115 119 924 928 B-cancer
cervical 120 128 929 937 I-cancer
cancer 129 135 938 944 I-cancer
, 135 136 944 945 O
or 137 139 946 948 O
other 140 145 949 954 O
cancer 146 152 955 961 O
for 153 156 962 965 O
which 157 162 966 971 O
the 163 166 972 975 O
patient 167 174 976 983 O
has 175 178 984 987 O
not 179 182 988 991 O
received 183 191 992 1000 O
treatment 192 201 1001 1010 B-treatment
for 202 205 1011 1014 O
one 206 209 1015 1018 B-upper_bound
year 210 214 1019 1023 I-upper_bound
prior 215 220 1024 1029 I-upper_bound
to 221 223 1030 1032 O
enrollment 224 234 1033 1043 O

Poorly 0 6 1044 1050 O
controlled 7 17 1051 1061 O
hypertension 18 30 1062 1074 B-chronic_disease
, 30 31 1074 1075 O
diabetes 32 40 1076 1084 B-chronic_disease
mellitus 41 49 1085 1093 I-chronic_disease
, 49 50 1093 1094 O
active 51 57 1095 1101 O
or 58 60 1102 1104 O
uncontrolled 61 73 1105 1117 O
hepatitis 74 83 1118 1127 B-chronic_disease

Pregnant 0 8 1128 1136 B-pregnancy

baseline 0 8 1137 1145 O
Alanine 9 16 1146 1153 B-clinical_variable
Aminotransferase 17 33 1154 1170 I-clinical_variable
( 34 35 1171 1172 I-clinical_variable
ALT 35 38 1172 1175 I-clinical_variable
) 38 39 1175 1176 I-clinical_variable
< 40 41 1177 1178 O
3x 42 44 1179 1181 B-upper_bound
Upper 45 50 1182 1187 I-upper_bound
Limit 51 56 1188 1193 I-upper_bound
of 57 59 1194 1196 I-upper_bound
Normal 60 66 1197 1203 I-upper_bound
( 67 68 1204 1205 I-upper_bound
ULN 68 71 1205 1208 I-upper_bound
) 71 72 1208 1209 I-upper_bound

nursing 0 7 1210 1217 O
women 8 13 1218 1223 B-gender
may 14 17 1224 1227 O
not 18 21 1228 1231 O
participate 22 33 1232 1243 O

other 0 5 1244 1249 O
serious 6 13 1250 1257 O
medical 14 21 1258 1265 O
or 22 24 1266 1268 O
psychiatric 25 36 1269 1280 B-chronic_disease
illness 37 44 1281 1288 I-chronic_disease
that 45 49 1289 1293 O
could 50 55 1294 1299 O
potentially 56 67 1300 1311 O
interfere 68 77 1312 1321 O
with 78 82 1322 1326 O
the 83 86 1327 1330 O
completion 87 97 1331 1341 O
of 98 100 1342 1344 O
treatment 101 110 1345 1354 B-treatment
according 111 120 1355 1364 O
to 121 123 1365 1367 O
this 124 128 1368 1372 O
protocol 129 137 1373 1381 O

unless 0 6 1382 1388 O
lower 7 12 1389 1394 O
levels 13 19 1395 1401 O
are 20 23 1402 1405 O
explained 24 33 1406 1415 O
by 34 36 1416 1418 O
extensive 37 46 1419 1428 O
bone 47 51 1429 1433 B-cancer
marrow 52 58 1434 1440 I-cancer
plasmacytosis 59 72 1441 1454 I-cancer

